Follow
Anne Moore
Anne Moore
Unknown affiliation
Verified email at ucc.ie - Homepage
Title
Cited by
Cited by
Year
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria
NW Schmidt, RL Podyminogin, NS Butler, VP Badovinac, BJ Tucker, ...
Proceedings of the National Academy of Sciences 105 (37), 14017-14022, 2008
3002008
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells
A Moore, P McGuirk, S Adams, WC Jones, JP McGee, DT O'Hagan, ...
Vaccine 13 (18), 1741-1749, 1995
2091995
Effective induction of high-titer antibodies by viral vector vaccines
SJ Draper, AC Moore, AL Goodman, CA Long, AA Holder, SC Gilbert, ...
Nature medicine 14 (8), 819-821, 2008
2002008
Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice
AC Moore, W Kong, BK Chakrabarti, GJ Nabel
Journal of virology 76 (1), 243-250, 2002
1712002
The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1
A Moore, L McCarthy, KHG Mills
Vaccine 17 (20-21), 2517-2527, 1999
1591999
Coated microneedle arrays for transcutaneous delivery of live virus vaccines
A Vrdoljak, MG McGrath, JB Carey, SJ Draper, AVS Hill, C O'Mahony, ...
Journal of controlled release 159 (1), 34-42, 2012
1582012
Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria
AC Moore, AVS Hill
Immunological reviews 199 (1), 126-143, 2004
1512004
Inhibition of IL-12 production in human monocyte-derived macrophages by TNF
X Ma, J Sun, E Papasavvas, H Riemann, S Robertson, J Marshall, ...
The Journal of Immunology 164 (4), 1722-1729, 2000
1422000
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications
P Galvin, D Thompson, KB Ryan, A McCarthy, AC Moore, CS Burke, ...
Cellular and Molecular Life Sciences 69, 389-404, 2012
1412012
Determination of parameters for successful spray coating of silicon microneedle arrays
MG McGrath, A Vrdoljak, C O’Mahony, JC Oliveira, AC Moore, AM Crean
International journal of pharmaceutics 415 (1-2), 140-149, 2011
1392011
Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration
MG McGrath, S Vucen, A Vrdoljak, A Kelly, C O’Mahony, AM Crean, ...
European Journal of Pharmaceutics and Biopharmaceutics 86 (2), 200-211, 2014
1362014
Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
A Reyes‐Sandoval, S Sridhar, T Berthoud, AC Moore, JT Harty, ...
European journal of immunology 38 (3), 732-741, 2008
1352008
The success of microneedle-mediated vaccine delivery into skin
S Marshall, LJ Sahm, AC Moore
Human vaccines & immunotherapeutics 12 (11), 2975-2983, 2016
1332016
Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance
AC Moore, A Gallimore, SJ Draper, KR Watkins, SC Gilbert, AVS Hill
The Journal of Immunology 175 (11), 7264-7273, 2005
1232005
The immune system and stroke: from current targets to future therapy
K Malone, S Amu, AC Moore, C Waeber
Immunology and cell biology 97 (1), 5-16, 2019
1042019
Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods
A Vrdoljak, EA Allen, F Ferrara, NJ Temperton, AM Crean, AC Moore
Journal of controlled release 225, 192-204, 2016
1042016
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum …
M Walther, FM Thompson, S Dunachie, S Keating, S Todryk, T Berthoud, ...
Infection and immunity 74 (5), 2706-2716, 2006
932006
Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity
CL Hutchings, SC Gilbert, AVS Hill, AC Moore
The Journal of Immunology 175 (1), 599-606, 2005
922005
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody-and T cell-mediated multistage protection against malaria
SJ Draper, AL Goodman, S Biswas, EK Forbes, AC Moore, SC Gilbert, ...
Cell host & microbe 5 (1), 95-105, 2009
892009
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
DP Webster, S Dunachie, S McConkey, I Poulton, AC Moore, M Walther, ...
Vaccine 24 (15), 3026-3034, 2006
892006
The system can't perform the operation now. Try again later.
Articles 1–20